更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
RION与龙沙合作扩大基于外泌体的治疗药物生产规模 - 新闻医学网
RION engages Lonza to scale manufacturing exosome based therapeutics News-Medical
RION携手龙沙扩大基于外泌体的治疗药物生产规模 - 商业电讯
RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics Business Wire
RION与龙沙合作开发可扩展外泌体药物生产技术 - 合同制药
RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing Contract Pharma
龙沙同意扩大RION基于外泌体疗法的生产规模——GEN《基因工程与生物技术新闻》报道
Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics GEN - Genetic Engineering and Biotechnology News
2025年十大合同开发与生产组织 - 基因工程与生物技术新闻
Top 10 Contract Development and Manufacturing Organizations 2025 GEN - Genetic Engineering and Biotechnology News
高浓度生物制剂的生产挑战 - 基因工程与生物技术新闻
Manufacturing Challenges with High-Concentration Biologics GEN - Genetic Engineering and Biotechnology News
罗氏在北卡罗来纳州启动建设价值7亿美元的肥胖症药物生产设施 - 激烈药业
Roche begins building $700M obesity drug manufacturing facility in N.C. Fierce Pharma
Thermo Fisher Scientific在梅班开设新制造工厂 - Chapelboro.com报道
Thermo Fisher Scientific Opens New Manufacturing Facility in Mebane Chapelboro.com
Thermo Fisher Scientific在北卡罗来纳州开设卓越制造中心——商业快讯
Thermo Fisher Scientific Opens Manufacturing Center of Excellence Site in North Carolina Business Wire
Cytiva推出新型ÄKTA readyflux系统,专为小规模生产设计——选自SelectScience
Cytiva launches new ÄKTA readyflux system for smaller scale manufacturing SelectScience
赛默飞世尔收购赛诺菲美国无菌药品生产基地——制药技术新闻
Thermo Fisher acquires Sanofi’s steriles manufacturing site in US Pharmaceutical Technology
龙沙高管谈生产准备:应对细胞与基因疗法挑战——亚洲生物科技视野
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge BioSpectrum Asia
Cytiva与Argonaut合作扩大欧美试剂冻干生产规模——BioSpace报道
Cytiva and Argonaut Collaborate to Expand Reagent Lyophilization Manufacturing in EU and US BioSpace
罗氏宣布投资5.5亿美元扩建印第安纳波利斯诊断制造中心——美通社
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub PR Newswire
罗氏效仿同行,向美国制造与研发基地投入500亿美元——FirstWord Pharma
Roche follows peers with $50B investment in US manufacturing, research sites FirstWord Pharma
龙沙集团投资大规模生物制造、生物偶联及药品生产领域——DCAT价值链洞察
Lonza Investing in Large-Scale Biomanufacturing, Bioconjugation, Drug-Product Manufacturing DCAT Value Chain Insights
马萨诸塞州制造厂将裁员85名员工——NBC波士顿报道
Massachusetts manufacturing facility to lay off 85 employees NBC Boston
Vaxcyte将Lonza位于Visp工厂的制造投资列为2024年关键支出——生物工艺国际报道
Vaxcyte cites manufacturing investments at Lonza facility in Visp as key 2024 expenditure BioProcess International
把品牌目录放在视野里,但不抢主叙事
把工具、CRO、生物制药和器械公司做成滚动资源带,作为资讯流下方的辅助索引。
查看关于页